Osteoclast differentiation inhibitors: a patent review (2008 – 2012)

By Kim Seong Hwan   Moon Seong-Hee  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1591-1610

Informa Healthcare

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 – 2012)

By Dolušić Eduard   Frédérick Raphaël  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1367-1381

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Phosphorylase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 845-857

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature

By Baker David J   Greenhaff Paul L   Timmons James A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 459-466

Informa Healthcare

Access to resources Recommend Favorite

Sulfonamides: a patent review (2008 – 2012)

By Carta Fabrizio   Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 747-758

Informa Healthcare

Access to resources Recommend Favorite